跳至主要内容
临床试验/NL-OMON27910
NL-OMON27910已完成不适用

TRIUMPH-Epidemiological validation and clinical implementation of candidate biomarkers in patients with acute heart failure.

Center for Translational Molecular Medicine0 个研究点目标入组 1,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,000

研究概览

简要总结

/A

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients to be included must meet the following criteria:
  • 1.Men and women, aged 18 years or older, capable of understanding and signing informed consent;

排除标准

  • Patients will be excluded from this study for any of the following reasons:
  • 1.Heart failure precipitated by a non-cardiac condition (e.g. severe anemia, pulmonary embolism, thyrotoxicosis, etc);

研究者

相似试验

Hartfalen biomarker studie (TRIUMPH). | 临床试验